Urine ACR Testing: Kidney Signal, Not a Longevity Score
Urine ACR can reveal kidney and vascular risk that blood tests may miss, but results need repeat testing, eGFR, and careful clinical context.
Resistant Starch and Gut Health: Useful, Not Magic
Resistant starch can feed gut microbes and modestly affect glucose markers, but foods, doses, and individual responses matter more than hype.
Sleep Apnoea After 50: Why Snoring Deserves Attention
Snoring after 50 is not a diagnosis, but paired with sleepiness, pauses or cardiovascular risk, it can justify a proper sleep apnoea assessment.
CoQ10 Supplements: Plausible, But Not a Statin Fix
CoQ10 has plausible biology and limited clinical signals, but evidence for statin muscle pain is mixed and medication interactions deserve caution.
Eccentric Training After 50: Useful, Not a Shortcut
Eccentric training can support strength and function after 50, but slower lowering work needs careful dosing, recovery, and joint-pain caution.
Prediabetes in Midlife: Risk Signal, Not a Forecast
Prediabetes is a useful warning signal, but not a diagnosis with a countdown. Here is what the evidence says about risk, testing, and limits.
Subclinical Hypothyroidism in Later Life: What Matters
Mild subclinical hypothyroidism in later life needs repeat testing, context, and caution. Treatment helps some adults, but not everyone benefits.
Mindfulness for Stress: Useful Practice, Not a Cure
Mindfulness can help some adults manage stress and anxiety symptoms, but benefits are modest, context-dependent, and not a substitute for care.
Cystatin C Testing: Kidney Signal, Not an Age Score
Cystatin C can sharpen kidney-risk assessment when creatinine is noisy, but it is a context marker for clinical decisions, not a longevity score.
Balance Training After 50: Useful, Not Fall Insurance
Balance training can reduce falls in older adults, but it works best as cautious, progressive practice alongside strength and medical context.